The NCCN ORP fosters innovation and knowledge discovery that improve the lives of patients with cancer.
Guiding Principles:
NCCN and AstraZeneca Quality Improvement Initiative: Quality Improvement in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) Research Grant Opportunity - Submit Proposals by 5:00 pm ET on Wednesday, June 5, 2024. Open to NCCN Member Institutions Only.
View the NCCN ORP Press Releases
View the NCCN ORP Scientific Publications
View the NCCN ORP Disclosure Policy